Record #22852
An interim analysis of real-world safety data from an ongoing, non-interventional, observational study of patients with inflammatory bowel disease treated with CT-P13, an infliximab biosimilar, in the context of usual care with reference infliximab
Publisher
Original paper date
Jan 25, 2019
Original DOI
Country
Institution
Open access
No
Article type
Broad categories
Citation lifecycle
How this paper is being cited
Pre-retraction
0
Same day
0
Post-retraction
0
% post-retraction
0.0%
~0.0 citations/yr before retraction · ~0.0 citations/yr after
— citing papers
Who is still citing this work
Loading…